Linda Peckel

A multidisciplinary team of scleroderma specialists developed a framework for a comprehensive and sustainable approach to treating scleroderma.

Rheumatologists and pulmonologists provide differing perspectives on risk factors, disease assessment, and treatment strategies for patients with rheumatoid arthritis-associated interstitial lung disease.

A possible bidirectional association between migraine and rheumatoid arthritis (RA) is investigated.

The relationship between atherosclerotic cardiovascular disease (CVD) and rheumatoid arthritis (RA) is detailed.

An overview of the history of genome-wide association studies (GWAS) for osteoporosis, and the existing challenges and recent developments in GWAS in the bone field.

Psoriasis and psoriatic arthritis have been associated with the underreporting and undertreatment of pain. To provide adequate care and management of pain in psoriatic disease, a multidisciplinary approach is required.

Katherine Wysham, MD, of the VA Puget Sound Health Care System explains how to avoid the use of glucocorticoids and employ screening tools to lessen the risk for osteoporotic fractures in patients with RA.

Several studies have assessed the potentially increased rate and the management of osteoporotic and fragility fractures during the COVID-19 pandemic.

The American College of Rheumatology developed guidelines for the management of gout, including use of urate-lowering therapy, flare treatment, and lifestyle and medication recommendations.

Experts have advised the evaluation of spondyloarthritis in patients with inflammatory bowel disease.

In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.

Researchers found that drugs used to treat rheumatoid arthritis have been associated with varicella zoster activation.

Weight loss in patients who are overweight or obese may improve symptoms through pathologic mechanisms in addition to reduction of joint burden.

Given the substantial overlap with RA, emerging theories suggest that undifferentiated arthritis represents a unique window of opportunity to intervene in the pathology of RA before it becomes established.

Preliminary evidence has found an association between the cannabinoid system and other rheumatic conditions, but the studies have not provided conclusive results that could drive recommendations.

Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.

Quality of life measurements capture unique information about systemic lupus erythematosus that are not included in disease activity or damage evaluations.

John M. Davis III, MD, MS, from the Mayo Clinic in Rochester, Minnesota, and Jennifer Gorman, MD, MPH, from The Polyclinic in Seattle, Washington, discuss the evolving collaborative care therapy model in RA.

Petros Efthimiou, MD, a rheumatologist at NYU Langone Health, discusses how clinicians should approach prescribing potentially teratogenic drugs in pregnancy.

Advances in the management of systemic lupus erythematosus have improved quality of life and outcomes for women who are considering pregnancy.

As a result of better management of rheumatoid arthritis, individuals with the condition are living longer. However, it is unknown if this represents different forms of the disease or a continuum of rheumatoid arthritis diagnosed at different stages.

Nonadherence to treatment regimens presents a barrier to optimal outcomes in RA and lupus.

Rapid expansion of effective therapies for psoriatic arthritis has driven new, ambitious treatment targets of minimal disease activity and disease remission.

Many variations of therapy for rheumatoid arthritis are now possible, and determining the optimal strategy for each patient is crucial to the success of treatment.

Fibromyalgia has remained a clinically nebulous entity, and one that is very difficult to manage effectively.

Thoracic manifestations are common in connective tissue disease, also called collagen vascular disease.

MRI allows to show changes to bone and cartilage, and to discriminate these from fluid and soft tissues around the joints, making it a good technique for measuring synovial volume and inflammation characteristic of RA.

Technological advances may assist children and adolescents with JIA, who are both more forgetful and more resistant to therapy.

The effect of rheumatic disease on vaccine safety in children was examined.

FENO monitoring may provide a biomarker of disease activity and signify the emergence of pulmonary involvement in kids with SLE.